DOJ and HHS-OIG Announce 2026 National Health Care Fraud Takedown with Significant Telemedicine and Genetic Testing Focus

What this means for your practice

This national health care fraud takedown signals a critical shift in federal enforcement priorities, with a pronounced focus on telemedicine and genetic testing. For telehealth brands, medspas, dental practices, and chiropractic offices, the message is clear: federal and state authorities are leveraging data and extensive coordination to identify and prosecute fraud, particularly within rapidly expanding sectors like telehealth. Practices engaging in telehealth, offering genetic testing services, or billing Medicaid must ensure impeccable compliance with federal and state regulations regarding medical necessity, billing accuracy, and patient care standards. The suspension and revocation of billing privileges for over 2,400 providers by CMS and HHS-OIG underscore the severe consequences of non-compliance, including exclusions and significant civil monetary penalties. Operators must proactively audit their billing practices, verify the legitimacy of all patient encounters, especially those conducted via telehealth, and rigorously ensure the medical necessity of all services rendered to mitigate enforcement risks.

Washington D.C. – The Department of Justice (DOJ) and the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) have announced the results of their 2026 National Health Care Fraud Takedown, a coordinated enforcement effort that has charged a record number of defendants in schemes totaling billions in alleged false claims. The takedown, announced on June 23, 2026, highlights a sharpened focus on emerging areas of fraud, particularly within the telemedicine and genetic testing sectors.

Broad-Based Enforcement and Record Numbers

This year's takedown involved the largest number of defendants in its history, with 455 individuals charged across 56 federal districts and 45 states and territories. Among the defendants were 90 doctors and other licensed medical professionals, accused of participating in schemes involving over $6.5 billion in alleged false claims. This expansive effort reflects a concerted strategy of nationally coordinated, data-driven enforcement aimed at intercepting fraudulent payments.

A significant portion of these charges directly targeted telemedicine and genetic testing fraud. Forty-nine (49) defendants were specifically charged in schemes related to these areas, involving over $1.17 billion in alleged false claims. This targeted approach underscores a clear regulatory signal regarding the vulnerabilities and associated risks within these rapidly evolving healthcare delivery models.

Unprecedented Coordination Across Agencies

The 2026 takedown showcased an unprecedented level of interagency cooperation. Fifty of the 53 state Medicaid Fraud Control Units (MFCUs) participated, marking the most extensive state involvement in Department history. Beyond criminal charges, other critical enforcement actions were undertaken:

• Centers for Medicare & Medicaid Services (CMS): Suspended 1,079 providers and revoked billing privileges for an additional 1,403 providers.
• HHS-OIG: Pursued over 1,400 exclusions and Civil Monetary Penalties Law (CMPL) actions, seeking more than $10 billion.

These administrative actions demonstrate a comprehensive strategy to not only prosecute fraud but also to prevent future fraudulent activities by removing bad actors from federal healthcare programs.

Medicaid Fraud Takes Center Stage

A central theme of this year's enforcement action was Medicaid fraud. Of the 455 defendants, 295 — nearly two-thirds — were charged with Medicaid fraud involving over $518 million in alleged false claims. This represents the largest number of Medicaid fraud defendants and the largest Medicaid loss amount charged in Department history.

The emphasis on Medicaid enforcement is a direct reflection of broader federal priorities. The DOJ attributed these results partly to expanded state coordination and the Acting Attorney General’s expansion of the Health Care Fraud Unit, which now includes 15 prosecutors dedicated to investigating Medicaid fraud nationwide. Furthermore, in April, CMS Administrator Dr. Mehmet Oz issued a nationwide directive requiring all 50 states to submit comprehensive, two-year strategies for auditing and revalidating high-risk Medicaid providers. This was followed by an HHS-OIG letter to state attorneys general regarding Medicaid fraud prevention, signaling a sustained federal commitment to safeguarding this vital program.

Implications for Healthcare Providers and Businesses

The 2026 National Health Care Fraud Takedown reinforces that enforcement agencies are increasingly sophisticated in their ability to detect and prosecute fraudulent schemes. The specific focus on telemedicine and genetic testing serves as a critical warning for providers and operators in these fields. Practices must demonstrate rigorous adherence to medical necessity requirements, maintain thorough documentation, and ensure that all services, especially those delivered remotely, meet the highest standards of care and compliance. The expansion of Medicaid fraud enforcement and enhanced interagency coordination mean that both federal and state authorities are closely scrutinizing claims submitted to public health programs. Proactive compliance measures, including internal audits, robust training programs, and vigilant oversight of billing practices, are more essential than ever to mitigate risks in this evolving regulatory landscape.

Source

• Enforcement Actions | Office of Inspector General | Government Oversight | U.S. Department of Health and Human Services

Key Facts

| Detail | Value | |---|---| | Announcement Date | June 23, 2026 | | Total Defendants Charged | 455 across 56 federal districts and 45 states/territories | | Total Alleged False Claims | Over $6.5 billion | | Telemedicine & Genetic Testing Focus | 49 defendants, over $1.17 billion in alleged false claims | | CMS Administrative Actions | 1,079 provider suspensions, 1,403 billing privilege revocations | | HHS-OIG Administrative Actions | Over 1,400 exclusions and Civil Monetary Penalties Law (CMPL) actions seeking more than $10 billion | | Medicaid Fraud Focus | 295 defendants, over $518 million in alleged false claims; 50 state Medicaid Fraud Control Units participated |

Frequently Asked Questions

What was the total scope of the 2026 National Health Care Fraud Takedown?

The takedown charged 455 defendants in schemes involving over $6.5 billion in alleged false claims, spanning 56 federal districts and 45 states and territories. It also included participation from 50 state Medicaid Fraud Control Units.

Was telemedicine a specific focus of this takedown?

Yes, a significant portion of the takedown specifically targeted telemedicine and genetic testing fraud. 49 defendants were charged in these areas, involving over $1.17 billion in alleged false claims.

What actions did CMS and HHS-OIG take against providers during this takedown?

CMS suspended 1,079 providers and revoked billing privileges for 1,403 providers. HHS-OIG pursued over 1,400 exclusions and Civil Monetary Penalties Law actions seeking more than $10 billion.

Why was Medicaid fraud emphasized in this takedown?

Medicaid enforcement was a central theme, with 295 defendants charged in Medicaid fraud schemes totaling over $518 million. This reflects a broader federal priority, supported by expanded state coordination, additional dedicated prosecutors, and a nationwide CMS directive requiring states to submit comprehensive strategies for auditing high-risk Medicaid providers.

Who was charged in the takedown?

A total of 455 defendants were charged, including 90 doctors and other licensed medical professionals.

Source: oig.hhs.gov — DOJ and HHS-OIG Announce 2026 National Health Care Fraud Takedown with Telemedicine Focus